349 related articles for article (PubMed ID: 8528047)
1. Erythropoiesis and erythropoietin in multiple myeloma.
Beguin Y
Leuk Lymphoma; 1995 Aug; 18(5-6):413-21. PubMed ID: 8528047
[TBL] [Abstract][Full Text] [Related]
2. Erythropoietin and the anemia of cancer.
Beguin Y
Acta Clin Belg; 1996; 51(1):36-52. PubMed ID: 8669161
[TBL] [Abstract][Full Text] [Related]
3. [Analysis of causes for anemia in patients with multiple myeloma].
Rokicka-Piotrowicz M; Paszkowska M; Król M; Król M; Kuratowska Z
Pol Arch Med Wewn; 2000 Dec; 104(6):843-51. PubMed ID: 11424663
[TBL] [Abstract][Full Text] [Related]
4. [Inadequate erythropoietin production (epo) in patients with multiple myeloma].
Kostova G; Siljanovski N
Prilozi; 2004; 25(1-2):53-66. PubMed ID: 15735535
[TBL] [Abstract][Full Text] [Related]
5. Defective iron supply for erythropoiesis and adequate endogenous erythropoietin production in the anemia associated with systemic-onset juvenile chronic arthritis.
Cazzola M; Ponchio L; de Benedetti F; Ravelli A; Rosti V; Beguin Y; Invernizzi R; Barosi G; Martini A
Blood; 1996 Jun; 87(11):4824-30. PubMed ID: 8639855
[TBL] [Abstract][Full Text] [Related]
6. Erythropoiesis in multiple myeloma: defective red cell production due to inappropriate erythropoietin production.
Beguin Y; Yerna M; Loo M; Weber M; Fillet G
Br J Haematol; 1992 Dec; 82(4):648-53. PubMed ID: 1482651
[TBL] [Abstract][Full Text] [Related]
7. Clinical results of recombinant erythropoietin in transfusion-dependent patients with refractory multiple myeloma: role of cytokines and monitoring of erythropoiesis.
Musto P; Falcone A; D'Arena G; Scalzulli PR; Matera R; Minervini MM; Lombardi GF; Modoni S; Longo A; Carotenuto M
Eur J Haematol; 1997 May; 58(5):314-9. PubMed ID: 9222286
[TBL] [Abstract][Full Text] [Related]
8. [Involvement of apoptosis and proinflammatory cytokines in the pathogenesis of anemia in multiple myeloma].
Grzaśko N
Postepy Hig Med Dosw (Online); 2004; 58():364-71. PubMed ID: 15536394
[TBL] [Abstract][Full Text] [Related]
9. [Erythropoietin in the pathogenesis of anemia in patients with multiple myeloma].
Rokicka-Piotrowicz M; Paluszewska M; Paszkowska M; Rakowska A; Wierzbicka E; Buras A; Kuratowska Z
Pol Arch Med Wewn; 1998 Mar; 99(3):218-23. PubMed ID: 9760808
[TBL] [Abstract][Full Text] [Related]
10. A single approach to targeting transferrin receptor 2 corrects iron and erythropoietic defects in murine models of anemia of inflammation and chronic kidney disease.
Olivari V; Di Modica SM; Lidonnici MR; Aghajan M; Cordero-Sanchez C; Tanzi E; Pettinato M; Pagani A; Tiboni F; Silvestri L; Guo S; Ferrari G; Nai A
Kidney Int; 2023 Jul; 104(1):61-73. PubMed ID: 36990212
[TBL] [Abstract][Full Text] [Related]
11. [Erythropoietin: biochemical characteristics, biologic effects, indications and results of use in hematology].
Marmont AM
Tumori; 1997; 83(4 Suppl 2):S3-15. PubMed ID: 9487378
[TBL] [Abstract][Full Text] [Related]
12. Recombinant human erythropoietin and the anemia of multiple myeloma.
Barlogie B; Beck T
Stem Cells; 1993 Mar; 11(2):88-94. PubMed ID: 8457789
[TBL] [Abstract][Full Text] [Related]
13. Cellular mechanism of resistance to erythropoietin.
Casadevall N
Nephrol Dial Transplant; 1995; 10 Suppl 6():27-30. PubMed ID: 8524490
[TBL] [Abstract][Full Text] [Related]
14. Quantitative assessment of erythropoiesis and functional classification of anemia based on measurements of serum transferrin receptor and erythropoietin.
Beguin Y; Clemons GK; Pootrakul P; Fillet G
Blood; 1993 Feb; 81(4):1067-76. PubMed ID: 8427988
[TBL] [Abstract][Full Text] [Related]
15. Iron and the anemia of chronic disease.
Spivak JL
Oncology (Williston Park); 2002 Sep; 16(9 Suppl 10):25-33. PubMed ID: 12380952
[TBL] [Abstract][Full Text] [Related]
16. Disease-related anemia in chronic lymphocytic leukemia is not due to intrinsic defects of erythroid precursors: a possible pathogenetic role for tumor necrosis factor-alpha.
Tsopra OA; Ziros PG; Lagadinou ED; Symeonidis A; Kouraklis-Symeonidis A; Thanopoulou E; Angelopoulou MK; Vassilakopoulos TP; Pangalis GA; Zoumbos NC
Acta Haematol; 2009; 121(4):187-95. PubMed ID: 19468203
[TBL] [Abstract][Full Text] [Related]
17. [Erythropoietin-beta in the treatment of anemia in patients with chronic renal insufficiency].
Dimković N
Med Pregl; 2001; 54(5-6):235-40. PubMed ID: 11759218
[TBL] [Abstract][Full Text] [Related]
18. Cessation of intensive treatment with recombinant human erythropoietin is followed by secondary anemia.
Piron M; Loo M; Gothot A; Tassin F; Fillet G; Beguin Y
Blood; 2001 Jan; 97(2):442-8. PubMed ID: 11154221
[TBL] [Abstract][Full Text] [Related]
19. The role of recombinant erythropoietin for the treatment of anemia in multiple myeloma.
Musto P
Leuk Lymphoma; 1998 Apr; 29(3-4):283-91. PubMed ID: 9684926
[TBL] [Abstract][Full Text] [Related]
20. [Influence of tumor necrosis factor-alpha and interferon-gamma on erythropoietin production and erythropoiesis in cancer patients with anemia].
Wang W; Zhang MH; Yu Y; Xu CG
Zhonghua Xue Ye Xue Za Zhi; 2007 Oct; 28(10):681-4. PubMed ID: 18399174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
